PMID- 17883973
OWN - NLM
STAT- MEDLINE
DCOM- 20071213
LR  - 20191110
IS  - 1522-8037 (Print)
IS  - 1522-8037 (Linking)
VI  - 9
IP  - 4
DP  - 2007 Aug
TI  - Gastroparesis in type 2 diabetes mellitus: prevalence, etiology, diagnosis, and 
      treatment.
PG  - 270-9
AB  - The worldwide epidemic of type 2 diabetes mellitus (T2DM) is a substantial 
      economic and social burden. Although gastroparesis associated with type 1 
      diabetes mellitus (T1DM) has been recognized for years, only recently have 
      studies shown that patients with T2DM also have high rates of gastroparesis. 
      Individuals with T2DM constitute 90% to 95% of the diabetic population. Unique 
      characteristics that distinguish this population are obesity, insulin resistance, 
      and associated comorbidities. These features highlight the importance of 
      investigating gastric emptying in individuals with T2DM and upper 
      gastrointestinal symptoms. The purpose of this review is to examine the 
      literature pertaining to diabetes and the effect of diabetes on gastric 
      neuromuscular function, with a focus on T2DM. An understanding of gastric 
      motility in T2DM is important to diagnose gastroparesis, to treat upper 
      gastrointestinal symptoms, and to restore normal gastric motility, which may 
      lead, in turn, to improved glucose control.
FAU - Intagliata, Nicolas
AU  - Intagliata N
AD  - Section on Gastroenterology, Wake Forest University Medical Center, Nutrition 
      Building, E-115, Medical Center Boulevard, Winston-Salem, NC 27157, USA.
FAU - Koch, Kenneth L
AU  - Koch KL
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Curr Gastroenterol Rep
JT  - Current gastroenterology reports
JID - 100888896
RN  - 0 (Antiemetics)
SB  - IM
MH  - Antiemetics/*therapeutic use
MH  - Diabetes Mellitus, Type 2/*complications/physiopathology
MH  - Diagnostic Techniques, Digestive System
MH  - Diet
MH  - Electric Stimulation Therapy/methods
MH  - Gastric Emptying
MH  - *Gastroparesis/diagnosis/epidemiology/etiology/therapy
MH  - Global Health
MH  - Humans
MH  - Prevalence
RF  - 72
EDAT- 2007/09/22 09:00
MHDA- 2007/12/14 09:00
CRDT- 2007/09/22 09:00
PHST- 2007/09/22 09:00 [pubmed]
PHST- 2007/12/14 09:00 [medline]
PHST- 2007/09/22 09:00 [entrez]
AID - 10.1007/s11894-007-0030-3 [doi]
PST - ppublish
SO  - Curr Gastroenterol Rep. 2007 Aug;9(4):270-9. doi: 10.1007/s11894-007-0030-3.